AZTR Leads EPS Revision Surge with 46% Gain; CRWD Jumps 19.6%
Stocks with upward EPS estimate revisions delivered strong gains during the week ended August 28, 2026. Azitra (AZTR) led with a 46.1% surge after its forward EPS revision rose 8.4pp, while CrowdStrike (CRWD) gained 19.6% following record earnings and a raised outlook. Xometry (XMTR), Emergent Biosolutions (EBS), and Cypherpunk Technologies (CYPH) also posted double-digit gains, signaling broad momentum in earnings-driven plays.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| AZTR | Healthcare | 2026-08-21 | +8.4pp | +46.1% |
| CRWD | Technology | 2026-08-24 | N/A | +19.6% |
| EBS | Healthcare | 2026-08-21 | N/A | +16.9% |
| XMTR | Industrials | 2026-08-20 | N/A | +15.8% |
| CYPH | Healthcare | 2026-08-24 | +85.4pp | +12.5% |
Why did AZTR stock jump in August 2026?
Azitra (AZTR) jumped 46.1% from $0.13 to $0.19 after analysts raised its forward EPS estimate for next year from 59.6% to 68.0% on August 21, 2026.
The upward revision, which highlighted improved profitability expectations, powered the stock despite no earnings news in the window. The healthcare sector momentum and the magnitude of the EPS revision suggest investors are pricing in a stronger earnings trajectory for the company.
AZTR EPS revision history → · Screener snapshot from 2026-08-21 →
FAQ: AZTR
Why did AZTR stock jump?
AZTR gained 46.1% (from $0.13 to $0.19) after its next-year EPS growth estimate was revised up from 59.6% to 68.0% on August 21, 2026.
What caused AZTR's surge?
The surge was driven by a significant upward revision to AZTR's forward EPS estimate, signaling stronger expected profitability, even in the absence of specific earnings-related news.
What is AZTR's EPS growth estimate?
AZTR's expected EPS growth for next year stands at 68.0%, up from 59.6% prior to the revision.
Why did CRWD stock jump in August 2026?
CrowdStrike (CRWD) jumped 19.6% from $190.68 to $227.96 after analysts raised its forward EPS growth estimate to 26.5% on August 24, 2026.
The stock surged further on August 27 following record-breaking Q2 earnings that beat estimates by 7% ($0.31 vs $0.29) and a raised full-year outlook. Cybersecurity sector strength, with peers like Okta also rallying, reinforced the move as investors cheered resilient security spending and AI-driven demand.
CRWD EPS revision history → · Screener snapshot from 2026-08-24 →
FAQ: CRWD
Why did CRWD stock jump?
CRWD rose 19.6% from $190.68 to $227.96 after analysts lifted its forward EPS growth estimate to 26.5% on August 24, 2026, and then surged on record Q2 earnings.
Is CRWD a buy after the rally?
Many analysts see continued upside, as CRWD beat Q2 EPS by $0.02, raised full-year guidance, and ARR grew 25% to $5.84 billion, though some caution on stretched valuations.
What is CRWD's EPS growth estimate?
Analysts expect CRWD's next-year EPS to grow by 26.5%, reflecting strong demand for its cybersecurity platform.
Why did EBS stock jump in August 2026?
Emergent Biosolutions (EBS) gained 16.9% from $5.08 to $5.94 after its forward EPS growth estimate was revised upward to 191.0% on August 21, 2026.
The dramatic improvement in expected earnings, likely tied to operational improvements or cost-cutting, drove buying interest despite no earnings-related news in the window. Healthcare sector enthusiasm and the sheer size of the EPS growth projection likely fueled the rally.
EBS EPS revision history → · Screener snapshot from 2026-08-21 →
FAQ: EBS
Why did EBS stock jump?
EBS rose 16.9% from $5.08 to $5.94 after its next-year EPS growth estimate was revised up, now standing at 191.0%.
What caused EBS's surge?
The surge is attributed to a significant upward revision in EBS's forward EPS growth estimate, signaling a strong expected earnings rebound, without any specific news catalyst.
What is EBS's EPS growth estimate?
EBS's expected EPS growth for next year is 191.0%, indicating a substantial anticipated increase from previous-year levels.
Why did XMTR stock jump in August 2026?
Xometry (XMTR) climbed 15.8% from $83.12 to $96.26 after its forward EPS growth estimate was revised to 84.4% on August 20, 2026.
The upward revision, reflecting stronger earnings prospects for the industrial tech marketplace, likely attracted investors even without earnings news. The industrials sector's resilience and XMTR's disruptive business model contributed to the momentum.
XMTR EPS revision history → · Screener snapshot from 2026-08-20 →
FAQ: XMTR
Why did XMTR stock jump?
XMTR rose 15.8% from $83.12 to $96.26 after analysts revised its next-year EPS growth estimate to 84.4% on August 20, 2026.
Is XMTR a buy after the rally?
XMTR's strong EPS growth estimate of 84.4% suggests improving profitability, but investors should consider the stock's valuation and sector trends.
What is XMTR's EPS growth estimate?
XMTR's expected EPS growth for next year is 84.4%, reflecting robust anticipated earnings expansion.
Why did CYPH stock jump in August 2026?
Cypherpunk (CYPH) surged 12.5% from $1.68 to $1.89 after analysts raised its forward EPS growth estimate from 254.6% to 340.0% on August 24, 2026 — an 85.4 percentage-point increase.
The massive revision, likely driven by new product developments or cost reductions, attracted buyers despite no earnings-related news. Healthcare sector speculation and the elevated growth expectations fueled the move.
CYPH EPS revision history → · Screener snapshot from 2026-08-24 →
FAQ: CYPH
Why did CYPH stock jump?
CYPH gained 12.5% (from $1.68 to $1.89) after its next-year EPS growth estimate was raised from 254.6% to 340.0% on August 24, 2026.
What caused CYPH's surge?
The surge was driven by an 85.4 percentage-point upward revision in CYPH's forward EPS growth estimate, even in the absence of earnings news.
What is CYPH's EPS growth estimate?
CYPH's expected EPS growth for next year is 340.0%, indicating an exceptional projected earnings increase.
Today's top performers highlight the market's strong appetite for stocks with upward earnings estimate revisions, particularly in healthcare and technology. The moves suggest that fundamental outlook improvements are a key driver of recent investor sentiment.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →